SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 472 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,790,887 | +9.6% | 376,106 | -0.6% | 0.03% | +12.0% |
| Q2 2023 | $72,823,977 | +94600.8% | 378,385 | -0.4% | 0.02% | -13.8% |
| Q1 2023 | $76,899 | -18.4% | 379,803 | -48.2% | 0.03% | -21.6% |
| Q4 2022 | $94,195 | -100.0% | 732,973 | -53.2% | 0.04% | -57.0% |
| Q3 2022 | $212,063,000 | -39.0% | 1,566,308 | -20.2% | 0.09% | -35.8% |
| Q2 2022 | $347,477,000 | +74.0% | 1,963,811 | +39.2% | 0.13% | +106.2% |
| Q1 2022 | $199,736,000 | -12.6% | 1,411,063 | -4.5% | 0.06% | -4.4% |
| Q4 2021 | $228,435,000 | -14.6% | 1,477,589 | -6.2% | 0.07% | -17.1% |
| Q3 2021 | $267,564,000 | +13.0% | 1,575,759 | -1.5% | 0.08% | +15.5% |
| Q2 2021 | $236,874,000 | +1.0% | 1,599,249 | -5.3% | 0.07% | -5.3% |
| Q1 2021 | $234,483,000 | -26.1% | 1,688,628 | -8.3% | 0.08% | -29.9% |
| Q4 2020 | $317,289,000 | – | 1,842,197 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |